Coronavirus and MS Reporting Database
COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society, Consortium of MS Centers and Multiple Sclerosis Society of Canada to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.
Description
More detailed information about this field from each metasource.
COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society, Consortium of MS Centers and Multiple Sclerosis Society of Canada to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.
metasource: Fairsharing.orgversion: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Webpage:
https://www.covims.org/Webpage
More detailed information about this field from each metasource.
https://www.covims.org/
metasource: Fairsharing.orgversion: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
PMID: 32951235
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Publications
More detailed information about this field from each metasource.
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
PMID: 32951235
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
-
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
PubMed citations: 4.
4 articles citing: Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study. PMID:34418735
Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center. PMID:33775354
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. PMID:33743151
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review. PMID:33429305
Tags:
Tags
More detailed information about this field from each metasource.
image
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
patient care
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
report
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Tags
More detailed information about this field from each metasource.
image
metasource: Fairsharing.orgversion: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
patient care
metasource: Fairsharing.orgversion: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
report
metasource: Fairsharing.orgversion: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
metasource: Fairsharing.org
version: FAIRsharing.org: Coronavirus and MS Reporting Database; Coronavirus and MS Reporting Database; DOI: https://doi.org/10.25504/FAIRsharing.MtkkWk; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Need help integrating and/or managing biomedical data?